Research interests

The main research line is “Imaging I3”: Infection, Inflammation, and (tumor)Immunology


  • Musculoskeletal: peripheral osteomyelitis, device-related infections such as prosthetic joint infections, diabetic foot infection, fracture-related infections

  • Cardiovascular: endocarditis, device-related infections such as vascular graft infections, intravascular prosthetic material infections

  • Sepsis/bloodstream infections: bacteremia, specific bacterial infections

  • Fungal infections

  • Infections in children



  • Amyloidosis

  • Sarcoidosis

  • Tuberculosis, HIV/AIDS

  • Atherosclerosis and vasculitis

  • Rejection and PTLD after organ transplantation

  • Inflammatory diseases in children

  • Sports injuries



  • Imaging autoimmune reaction/checkpoints in tumors

  • Imaging of lymphocytes

  • Imaging of macrophages


Societal impact:

  • Development of diagnostic and therapeutic flowcharts in infectious and inflammatory diseases

  • Publication of several Dutch (NFU, NVNG) and European (EANM) guidelines/recommendations

  • Development and implementation of new specific tracers in infectious and inflammatory diseases (IL-2, PD1/PDL1, sorbitol, labelled antibiotics, labelled antifungal drugs)

  • Improvement of existing techniques for infection imaging (new protocols for white blood cell scintigraphy and FDG-PET)

  • Role of nuclear medicine in therapy evaluation of infectious and inflammatory diseases and during/after immunotherapy


Besides this Imaging I3 research line, I also perform some research in the field of oncology (this is also the main differential diagnosis with infectious diseases in PET):

  • Imaging of hormonal receptors (FES-PET, FDHT-PET)

  • Imaging of brain tumors

  • Imaging of apoptosis

  • Imaging lymphomas

Other research tasks:

  • Co-chair research Medical Imaging Center

  • Responsible person for contract research Medical Imaging Center

  • Coordinator of the research line Oncology, Infection and Transplantation

  • Writing publications and grant applications

  • Writing Dutch (NFU, NVNG) and European (EANM) guidelines/recommendations

  • Reviewer of manuscripts

  • Collaboration with many external centers (Netherlands, Europe and worldwide) 

  1. A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions using 18F-FES PET/CT imaging

    Jager, A., de Vries, E. G. E., der Houven van Oordt, C. W. M., Neven, P., Venema, C. M., Glaudemans, A. W. J. M., Wang, Y., Bagley, R. G., Conlan, M. G. & Aftimos, P., 11-Sep-2020, In : Breast cancer research. 22, 1, p. 97

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Whole body PD-L1 PET in patients with NSCLC and melanoma.

    Leung, D. K., De Langen, J., Raunig, D., Niemeijer, A-L. N., Smit, E. F., Boellaard, R., Vállez García, D., Dongen, G. A. M. S. V., Windhorst, A. D., Huisman, M. C., Glaudemans, A. W. J. M., Hendrikse, N. H., Smith, R. A., Poot, A. J., Lipovsek, D., Donnelly, D. J., Bonacorsi, S. J., Velasquez, L. M., Du, S. & Hayes, W., 10-Feb-2018, In : Journal of Clinical Oncology. 36, 5_suppl, p. 139 1 p.

    Research output: Contribution to journalMeeting AbstractAcademic

View all (276) »

  1. Tekke Huizing price for best PhD thesis of 2014

    Andor Glaudemans (Recipient), 20-Nov-2014


View all (1) »

  1. Diagnostics (Journal)

    Andor Glaudemans (Editorial board member)

    Activity: Publication peer-review and editorial workEditorial activityAcademic

  2. European Radiology Experimental (Journal)

    Andor Glaudemans (Editorial board member)
    2018 → …

    Activity: Publication peer-review and editorial workEditorial activityAcademic

  3. Clinical and Translational Imaging (Journal)

    Andor Glaudemans (Editorial board member)

    Activity: Publication peer-review and editorial workEditorial activityAcademic

View all (19) »

ID: 496686